Abstracts tagged "Obesity and systemic lupus erythematosus (SLE)"

Abstract Number: 706 • 2017 ACR/ARHP Annual Meeting
Elevated Erythrocyte Sedimentation Rate Among Obese Patients with SLE- Not Always a Marker of Disease Activity
George Stojan¹, Erik Barr² and Michelle Petri³, ¹Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, ³Medicine (Rheumatology), Division of Rheumatology, Johns Hopkins University School of Medicine, MD, USA, Baltimore, MD
Background/Purpose: Obesity is more common in patients with SLE compared to the general population. The prevalence of obesity among SLE patients is between 28 and…
Abstract Number: 1634 • 2017 ACR/ARHP Annual Meeting
Body Mass Index and Disease Activity in Systemic Lupus Erythematosus- a Paradoxical Relationship?
George Stojan¹, Wei Fu² and Michelle Petri³, ¹Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Medicine (Rheumatology), Division of Rheumatology, Johns Hopkins University School of Medicine, MD, USA, Baltimore, MD
Background/Purpose: Obesity is more common in patients with SLE compared to the general population. The prevalence of obesity among SLE patients is between 28 and…
Abstract Number: 1636 • 2017 ACR/ARHP Annual Meeting
Body Mass Index at Disease Onset Is Predictive of Future Organ Damage in Systemic Lupus Erythematosus
George Stojan¹, Wei Fu² and Michelle Petri³, ¹Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Medicine (Rheumatology), Division of Rheumatology, Johns Hopkins University School of Medicine, MD, USA, Baltimore, MD
Background/Purpose: Obesity is more common in patients with SLE compared to the general population. The prevalence of obesity among SLE patients is between 28…
Abstract Number: 1084 • 2014 ACR/ARHP Annual Meeting
Obesity Is a Risk Factor for Depression in Systemic Lupus Erythematosus (SLE)
Patricia P. Katz¹, Stephanie Rush², Laura Trupin³, Jennifer Barton³, Gabriela Schmajuk³, Jinoos Yazdany³, Chris Tonner⁴ and Mary Margaretten³, ¹Medicine, University of California, San Francisco, CA, ²University of California, San Francisco, San Francisco, CA, ³Medicine, University of California, San Francisco, San Francisco, CA, ⁴3333 California Street, Box 09, University of California, San Francisco, San Francisco, CA
Background/Purpose: General population studies have found significant relationships between obesity and depression, including identifying obesity as a risk factor for onset of depression. In SLE,…
Abstract Number: 1399 • 2012 ACR/ARHP Annual Meeting
Regional Fat Distribution Is Independently Associated with Damage Accrual in Systemic Lupus Erythematosus Female Patients
Manuel F. Ugarte-Gil¹, Rocio V. Gamboa-Cardenas², Karim E. Diaz-Deza², Mariela Medina-Chinchon¹, J. Mariano Cucho-Venegas¹, Risto A. Perich-Campos¹, Jose L. Alfaro-Lozano¹, Alfredo A. Sanchez-Torres², Zoila Rodriguez-Bellido¹, Sheyla Rodriguez-Ulloa² and Cesar A. Pastor-Asurza¹, ¹Rheumatology, Hospital Guillermo Almenara, EsSalud, Lima, Peru, ²Rheumatology, Hospital Almenara, Lima, Peru
Background/Purpose: In general population, a higher trunk fat and the ratio of trunk fat to leg fat (trunk-leg ratio) increase the risk for a cardiovascular…
Abstract Number: 1400 • 2012 ACR/ARHP Annual Meeting
Predictors of Obesity in Systemic Lupus Erythematosus
Michelle Petri¹, Sesha Adusumilli² and Hong Fang¹, ¹Johns Hopkins University School of Medicine, Baltimore, MD, ²Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Hypertension and obesity are the two most important traditional cardiovascular risk factors in the prediction of subclinical measures of atherosclerosis in SLE. Obesity is…
Abstract Number: 640 • 2012 ACR/ARHP Annual Meeting
Association of Body Weight with Cardiovascular Events in Systemic Lupus Erythematosus
George Stojan¹, Homa Timlin², Hong Fang³, Laurence S. Magder⁴ and Michelle Petri³, ¹Division of Rheumatology, Harvard Medical School- Beth Israel Deaconess Medical Center, Boston, MA, ²West Drayton, United Kingdom, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD
Background/Purpose: Excessive body mass among healthy subjects carries an increased risk of subsequent cardiovascular (CV) events. In healthy subjects, the relationship between body mass index…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].